Articles published by AstraZeneca![]() ![]() ![]() ![]()
AstraZeneca’s H1 and Q2 2024 Financial Results
July 25, 2024
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AstraZeneca sets ambition to deliver $80 billion Total Revenue by 2030 and sustained growth post 2030
May 21, 2024
From AstraZeneca
Via Business Wire
Tickers
AZN
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
AstraZeneca to acquire Fusion to accelerate the development of next-generation radioconjugates to treat cancer
March 19, 2024
From AstraZeneca
Via Business Wire
Tickers
AZN
![]()
AstraZeneca caps patient out-of-pocket costs at $35 per month for its US inhaled respiratory portfolio
March 18, 2024
From AstraZeneca
Via Business Wire
Tickers
AZN
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|